ID17194A - Metode pengobatan inflamasi - Google Patents

Metode pengobatan inflamasi

Info

Publication number
ID17194A
ID17194A IDP971448A ID971448A ID17194A ID 17194 A ID17194 A ID 17194A ID P971448 A IDP971448 A ID P971448A ID 971448 A ID971448 A ID 971448A ID 17194 A ID17194 A ID 17194A
Authority
ID
Indonesia
Prior art keywords
inflamation
treatment method
treatment
inflamation treatment
Prior art date
Application number
IDP971448A
Other languages
English (en)
Indonesian (id)
Inventor
Sidney R Smith
Satwant K Narula
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ID17194A publication Critical patent/ID17194A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2066IL-10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IDP971448A 1996-05-03 1997-04-30 Metode pengobatan inflamasi ID17194A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/642,816 US5753218A (en) 1996-05-03 1996-05-03 Method for treating inflammation

Publications (1)

Publication Number Publication Date
ID17194A true ID17194A (id) 1997-12-11

Family

ID=24578143

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971448A ID17194A (id) 1996-05-03 1997-04-30 Metode pengobatan inflamasi

Country Status (15)

Country Link
US (1) US5753218A (fr)
EP (1) EP0906118A1 (fr)
JP (1) JP2000509715A (fr)
KR (1) KR20000010706A (fr)
AR (1) AR006932A1 (fr)
AU (1) AU718857B2 (fr)
BR (1) BR9708908A (fr)
CA (1) CA2253312A1 (fr)
HU (1) HUP9903144A3 (fr)
ID (1) ID17194A (fr)
IL (1) IL126759A0 (fr)
NZ (1) NZ332464A (fr)
PE (1) PE64498A1 (fr)
WO (1) WO1997041882A1 (fr)
ZA (1) ZA973707B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US5800268A (en) 1995-10-20 1998-09-01 Molnick; Melvin Method of participating in a live casino game from a remote location
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
MXPA01010480A (es) * 1999-04-13 2002-03-27 Schering Corp Usos novedosos de la proteina 0x2 de mamifero y reactivos relacionados.
US6544504B1 (en) 1999-07-28 2003-04-08 Schering Corporation Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
WO2001008696A2 (fr) * 1999-07-28 2001-02-08 Schering Corporation Utilisation combinee d'interleukine 10 et de methotrexate pour therapie immunomodulatrice
WO2001008717A1 (fr) * 1999-08-03 2001-02-08 Smith & Nephew, Inc. Dispositifs implantables a liberation regulee
CA2431206C (fr) * 2000-12-08 2009-09-01 Takeda Chemical Industries, Ltd. Medicaments combines contenant un compose cycloalcene antisepticemique
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2003030720A2 (fr) * 2001-10-09 2003-04-17 The Children's Hospital Of Philadelphia Matieres et methodes de prevention ou de diminution de la formation de cicatrices
WO2003045322A2 (fr) * 2001-11-28 2003-06-05 Schering Corporation Methode permettant de traiter et de prevenir la pancreatite
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9511076B2 (en) * 2008-05-30 2016-12-06 Clarion Research Group Formulations and methods for recovery from dental surgery
US20120195938A1 (en) * 2007-05-30 2012-08-02 James Louis Rutkowski Formulations and methods for recovery from dental surgery
US20140294922A1 (en) * 2010-12-22 2014-10-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound with antibacterial activity
CA2928526A1 (fr) 2013-11-01 2015-05-07 Spherium Biomed S.L. Corps d'inclusion pour administration transdermique d'agents therapeutiques et cosmetiques
KR102624174B1 (ko) * 2020-09-18 2024-01-23 주식회사 아미코젠파마 수가용화된 담즙산을 포함하는 패혈증, 급성 폐손상 질환, 또는 급성 호흡곤란증후군의 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
WO1989004838A1 (fr) * 1987-11-25 1989-06-01 Immunex Corporation Recepteurs d'interleukine-1
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods
US5300292A (en) * 1991-05-03 1994-04-05 The Regents Of The University Of California Composition and method for treating inflammation
ES2138976T3 (es) * 1991-08-06 2000-02-01 Schering Corp Uso de analogos o antagonistas de interleucina-10 para tratar la toxicidad inducida por endotoxinas o superantigenos.
US5368854A (en) * 1992-08-20 1994-11-29 Schering Corporation Use of IL-10 to treat inflammatory bowel disease
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
CA2228620A1 (fr) * 1995-08-07 1997-02-20 John E. Oakes Traitement d'inflammations oculaires avec de l'interleukine-10

Also Published As

Publication number Publication date
CA2253312A1 (fr) 1997-11-13
HUP9903144A2 (hu) 2000-03-28
HUP9903144A3 (en) 2000-11-28
BR9708908A (pt) 1999-08-03
US5753218A (en) 1998-05-19
AU2808997A (en) 1997-11-26
NZ332464A (en) 2000-07-28
ZA973707B (en) 1997-10-29
IL126759A0 (en) 1999-08-17
JP2000509715A (ja) 2000-08-02
PE64498A1 (es) 1998-10-29
KR20000010706A (ko) 2000-02-25
AR006932A1 (es) 1999-09-29
EP0906118A1 (fr) 1999-04-07
WO1997041882A1 (fr) 1997-11-13
AU718857B2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
DE59708166D1 (de) Röntgenaufnahme-Verfahren
NO983266D0 (no) Distribuert Behandling
KR960008976A (ko) 처리장치 및 처리방법
ID17194A (id) Metode pengobatan inflamasi
NO992237D0 (no) Vannbehandlingsprosess
FI965091A0 (fi) Laskentamenetelmä ja -laite
DE69519583D1 (de) Schlammentwässerungsverfahren
NO990449D0 (no) FremgangsmÕte for hydrogenbehandling
DE69718808D1 (de) Plasmabehandlungsmethode
EE9600094A (et) Heitvee puhastusmeetod ja -seade
NO983263L (no) Distribuert behandling
DE69514960D1 (de) Schlackbehandlungssystem und -methode
ID19570A (id) Metode merawat tanaman kotiledonous
DE69942195D1 (de) Prozesssystem und -verfahren
ATE249436T1 (de) Herstellungsverfahren
ID16247A (id) Metode baru
KR970062320U (ko) 대규모 오수 처리 시설
DE69717846D1 (de) Behandlungsverfahren von laktamen
DE69731574D1 (de) Kompiliergerät und -verfahren
ID18300A (id) Metoda penemperan
BR9612503A (pt) Codificador auto-inicializado e método do mesmo
ID16924A (id) Metode perlakuan poliolefin
ID16400A (id) Metoda pengolahan air limbah
ID16225A (id) Metode pengeringan
EE9600113A (et) Reovee puhastamise meetod ja seade